Malignant Neoplasm of Stomach Active Not Recruiting Phase 3 Trials for Capecitabine (DB01101)

Also known as: Gastric Cancers / Stomach Cancer / Gastric cancer / Gastric Malignancies / Gastric cancer NOS / Cancer of Stomach / Malignant neoplasm of stomach, unspecified / Gastric malignancy

IndicationStatusPhase
DBCOND0045917 (Malignant Neoplasm of Stomach)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02872116Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction CancerTreatment
NCT01774786A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric CancerTreatment
NCT02114359Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric CancerTreatment
NCT00407186Randomized Phase III Trial of Adjuvant Chemotherapy or Chemoradiotherapy in Resectable Gastric Cancer (CRITICS)Treatment
NCT01470742Trial Comparing Capecitabine Plus Oxaliplatin (XELOX) and Capecitabine (X) as First-line Chemotherapy in Elderly Patients With Advanced Gastric CancerTreatment